BDBM622344 4-amino-N-(1-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-6-methylisoquinolin-5-yl)quinazoline-8-carboxamide ::US20230312556, Compound 77

SMILES COc1ccc(CNc2ncnc3c(cccc23)C(=O)Nc2c(C)ccc3c(Nc4ccc5OCCOc5c4)nccc23)c(OC)c1

InChI Key InChIKey=ZYPYCQRAGUSZBZ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 622344   

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Sichuan Kelun-Biotech Biopharmaceutical

US Patent
LigandPNGBDBM622344(4-amino-N-(1-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl...)
Affinity DataIC50: 7.90nMAssay Description:Assay protocol: the inhibitory effects of the compounds of the present invention on the wild-type BRAF enzyme, mutant CRAF enzyme (RAF1 Y340D and Y34...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
US Patent